top of page

Who Actually Treated You? “Cigna Authorized It” Does Not Explain Wildflower’s Claims

Rachael Lara
Oct 2
5 min read

Updated: Oct 12


You receive lactation care from an independent practice. That practice schedules your visit, performs your care, and maintains your clinical documentation.

Then the insurance claim identifies Wildflower as the billing and rendering entity.

Wildflower’s explanation, as communicated to Sunshyn, is that Cigna authorized the arrangement.

That explains what Wildflower says the payer permits. It does not fully explain what the treating provider authorized—or how the signed provider agreement supports the representation on the claim.

Cigna’s approval of a billing structure and the independent provider’s authorization are separate questions. Both deserve documented answers.

Different claim roles have different meanings

Healthcare claims can legitimately identify different people and organizations.

The clinician performing a service, the group billing for it, the service location, and the entity receiving payment may have different names. A billing company may also prepare and transmit claims on a practice’s behalf.

Different names therefore do not automatically establish an improper claim.

The question is whether those names accurately reflect an authorized relationship.

Handling a practice’s billing does not, by itself, establish that the billing company furnished the clinical care.

What Sunshyn has identified

Claims reviewed by Sunshyn identify Wildflower as the billing and rendering entity for care performed by independent lactation practices.

The provider agreement reviewed by Sunshyn appoints Wildflower as a billing and collection agent for services performed by the contractor.

That establishes an agency role. Sunshyn has not identified language expressly authorizing Wildflower to represent itself as the rendering entity for the independent practice’s services.

This is a finding about the agreements reviewed—not a determination that no other authority could exist.

If another provision, enrollment structure, or approved relationship supplies that authority, Cigna and Wildflower should identify it and explain how the treating provider became part of it.

What does Cigna’s permission actually establish?

Cigna can establish the billing arrangements it accepts and recognize appropriately structured provider relationships.

But an agreement between Cigna and Wildflower does not, by itself, demonstrate the independent practice’s authorization for every representation made about its services.

The connection needs to be explained.

What did the treating practice authorize? Which contractual provision supports the provider roles used on the claim? What enrollment or affiliation records establish the relationship?

“Cigna gave us permission” leaves those questions unanswered.

If payer permission were enough, where would it stop?

Consider the consequence of treating Cigna’s permission as the complete source of authority.

What limits Wildflower’s claims to services from practices that agreed to participate? What distinguishes those services from lactation care performed by another independent practice treating a Cigna member?

This is not an allegation that Wildflower submits claims for every lactation visit nationwide. It is a question about the boundary of the authority it asserts.

The provider relationship must matter.

If the signed agreement authorizes billing and collection, while the claim structure relies on a broader clinical-group relationship, where was that broader relationship established?

A payer’s willingness to accept a claim does not explain every authority needed to submit it in that form.

A billing agent is not automatically the treating practice

Independent practices routinely hire companies to prepare claims, follow up with insurers, and collect payment where authorized.

Those functions do not automatically turn the agent into the clinical entity that provided the service.

An organizational NPI also does not, by itself, explain how independently owned practices became part of that organization for billing purposes.

The underlying relationship needs to be clear.

Did the provider join a clinical group? Did the provider authorize a particular rendering representation? How does the payer recognize that affiliation? What responsibilities accompany it?

Providers should be able to understand those answers from accessible documentation.

Access to patient information does not settle the question

Wildflower receives information needed to process claims for the provider’s services.

But access to patient and clinical information does not, by itself, explain the authority to identify a particular organization as the billing or rendering provider.

A company may have permission to handle information and submit claims while still needing to explain the provider identity used on those claims.

The agreement should make that distinction understandable.

Information access, billing agency, and clinical-group participation are separate issues.

“Group practice” needs a documented relationship

Wildflower has described its billing in terms of a group arrangement.

Group billing can be legitimate. But calling an arrangement a group does not explain how each independent practice fits into it.

The agreement reviewed by Sunshyn describes management services and a billing and collection relationship. Sunshyn has not identified language expressly establishing the independent practice as a Wildflower clinical-group member.

Cigna and Wildflower should reconcile those descriptions.

What establishes the affiliation? Which clinicians and locations are included? How are the treating providers evaluated? What responsibilities does Wildflower assume?

The contracts, enrollment records, and claims should describe a coherent relationship.

Patients have a stake in the answer

Patients deserve to understand why their insurance paperwork identifies a company different from the practice they visited.

They may need to know whether that company furnished care or acted as an intermediary, which entity participates in their network, and where to direct a billing concern.

A different name can appear on legitimate paperwork. The patient still deserves an explanation.

Without one, a claim may leave the family uncertain about who provided the service and what the network arrangement means for their care.

Providers deserve to understand how their work is represented

Clinicians have a direct interest in claims submitted for their services.

Their documentation supports the care performed. Their agreement defines the role they authorized Wildflower to undertake.

They should be able to review how their services are represented, understand the authority supporting that representation, and obtain corrections when needed.

If Wildflower relies on an undisclosed payer agreement, providers should receive enough information to verify the requirements affecting their own work.

They should not be expected to accept an unexplained claim structure simply because another company controls submission.

Requests for answers have reached a dead end

Sunshyn and providers have sought explanations about the claim structure and its authority.

Cigna has redirected questions to Wildflower without substantively resolving them. Wildflower has invoked its Cigna arrangement without supplying the relevant supporting terms. It has also declined to provide the requested compliance or legal department contact.

The result is that claims continue to be submitted while the people whose care and services they represent cannot verify the basis for the arrangement.

Commercial confidentiality does not prevent an explanation of the relevant authority. It does not prevent identifying a responsible contact to review concerns.

An agreement may be private. The representation of independent providers’ clinical services is not beyond accountability.

“Cigna authorized it” is the beginning of an explanation

This concern is directed at the structure Cigna and Wildflower have established—not at clinicians trying to obtain payment for care they performed.

The companies should identify both sides of that structure: what Cigna approved and what the treating provider authorized.

They should explain how the provider agreement supports the claim roles used and give providers a meaningful route to review claims submitted for their work.

Patients deserve to understand who their insurance says treated them. Providers deserve to understand how their services are represented. Both deserve documentation instead of a circular referral between companies.


Sunshyn practice resources


For help with claim submission and payer follow-up, see Sunshyn's medical billing services.


For a structured review of documentation and practice requirements, explore the Documentation & Compliance learning pathway in the Sunshyn Learning Center.

Recent Posts

See All

Comments


bottom of page